Research Article
Application of Antithrombotic Drugs in Different Age-Group Patients with Upper Gastrointestinal Bleeding
Table 3
Effect of antithrombotic drug application on prognosis of patients in the two groups.
| | Elderly group | Young group | Length of stay (days) | Rebleeding | Mortality | Length of stay (days) | Rebleeding | Mortality |
| History of AP | Y | | 6 (0.053%) | 5 (0.044%) | | 0 (0%) | 0 (0%) | N | | 16 (0.049%) | 15 (0.046%) | | 5 (0.021%) | 1 (0.004%) | | 0.154 | 0.865 | 0.939 | 0.100 | 0.400 | 0.709 | History of AC | Y | | 0 (0%) | 1 (0.091%) | | 0 (0%) | 0 (0%) | N | | 22 (0.051%) | 19 (0.044%) | | 5 (0.019%) | 1 (0.004%) | | 0.277 | 0.443 | 0.459 | 0.148 | 0.891 | 0.951 | AP after UGIB | Y | | 3 (0.058%) | 2 (0.038%) | | 0 (0%) | 0 (0%) | N | | 19 (0.049%) | 18 (0.046%) | | 5 (0.02%) | 1 (0.004%) | | 0.040 | 0.777 | 0.805 | 0.054 | 0.461 | 0.744 | AC after UGIB | Y | | 6 (0.176%) | 3 (0.088%) | | 0 (0%) | 0 (0%) | N | | 16 (0.039%) | 17 (0.042%) | | 5 (0.019%) | 1 (0.004%) | | <0.001 | <0.001 | 0.208 | 0.609 | 0.713 | 0.870 |
|
|